Lineage Cell Therapeutics, Inc. Proceeds from Issuance of Private Placement
Lineage Cell Therapeutics, Inc. (LCTX) reported Proceeds from Issuance of Private Placement of $5.00 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2014-03-17
- Lineage Cell Therapeutics, Inc. proceeds from issuance of private placement for the quarter ending 2013-09-30 was $0.00.
- Lineage Cell Therapeutics, Inc. proceeds from issuance of private placement for fiscal 2012 was $286.55K.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $5.00M 10-Q · filed 2013-11-12 | ||
| 2013-06-30 | $5.00M 10-Q · filed 2013-08-09 | |||
| 2012-12-31 | $286.55K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |